Symbicort Aerosphere® (budesonide/formoterol) – New formulation approval
April 28, 2023 - The FDA approved AstraZeneca’s Symbicort Aerosphere (budesonide/formoterol), for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
Download PDF
